MDTNYSEElectromedical & Electrotherapeutic ApparatusFiscal year ends April 24

Medtronic plc

Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 3, 2026

$92.77−1.98 (-2.09%)

Close on Oct 19, 2026

Market cap: $119.22B
P/E (TTM): 22.8
Dividend yield: 3.06%

Fundamental chart

Pick a measure to chart its full history

$36.36BFY2026, +6.2% a year since FY2013

Where these numbers come from

Parsed from the XBRL in Medtronic's annual and quarterly filings with the SEC
Per-share figures adjusted for the 2-for-1 split on Sep 27, 1999
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing

Against peers

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is MDT.

Revenue growth9.8% · median 8.5%

Gross margin65.0% · median 46.9%

Operating margin18.1% · median 10.7%

Net margin13.9% · median 5.5%

Company	Revenue	Growth
MDT	$37.54B	+9.8%
SYK	$25.84B	+8.5%
BDX	$23.25B	+17.4%
BSX	$21.00B	+13.5%
BAX	$11.47B	+5.4%
ITGR	$1.84B	+2.7%

Company

Next earnings (est.): Nov 17, 2026, before open
Exchange: NYSE
Industry: Electromedical & Electrotherapeutic Apparatus
Fiscal year ends: April 24
Employees: 95,000
Held by institutions: 86.5%
Auditor: PricewaterhouseCoopers LLP
SEC CIK: 1613103

Advertisement
300 × 250